Pandion Therapeutics Inc (PAND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PAND | BMY | AMGN | GILD | VRTX |
| Company | Pandion Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 59.95 | 73.21 | 249.96 | 84.65 | 304.56 |
| High | 60.05 | 74.47 | 249.96 | 86.97 | 306.40 |
| Low | 59.95 | 72.61 | 242.21 | 83.62 | 300.75 |
| Last | 60.05 | 74.45 | 245.17 | 84.50 | 301.02 |
| Change | +0.13 | +1.68 | -1.36 | +3.11 | -2.76 |
| % Change | +0.22% | +2.31% | -0.55% | +3.82% | -0.91% |
| Volume | 241,500 | 10,211,800 | 3,072,900 | 12,852,400 | 1,621,400 |
| 20-Day Average Volume | 267,345 | 8,647,345 | 2,545,710 | 6,954,795 | 1,529,055 |
| Previous Close | 59.92 | 72.77 | 246.53 | 81.39 | 303.78 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 60.07 | 72.57 | 261.08 | 84.56 | 306.98 |
| 20-Day Raw Stochastic | 19.40% | 89.42% | 21.75% | 51.47% | 43.76% |
| 20-Day Relative Strength | 86.37% | 53.22% | 30.16% | 51.17% | 46.75% |
| Weighted Alpha | +75.62 | +10.30 | +4.90 | +38.80 | +20.80 |
| Today's Opinion | N/A | 16% Buy | 8% Sell | 40% Buy | 48% Buy |
| Previous Opinion | N/A | 40% Sell | 8% Sell | 40% Buy | 72% Buy |
| Last Month's Opinion | N/A | 24% Sell | 40% Buy | 80% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/24/21 | +2.76% since 01/27/23 | -3.34% since 01/27/23 | +0.92% since 01/27/23 | -6.36% since 01/27/23 |
| Low | 59.92 on 03/30/21 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 300.75 on 02/03/23 |
| High | 60.14 on 03/25/21 | 74.47 on 02/03/23 | 254.16 on 01/30/23 | 86.97 on 02/03/23 | 325.19 on 01/31/23 |
| 1-Month | |||||
| %Chg | -0.25% since 02/26/21 | +3.03% since 01/03/23 | -6.30% since 01/03/23 | -1.04% since 01/03/23 | +5.24% since 01/03/23 |
| Low | 59.60 on 03/04/21 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 80.48 on 02/02/23 | 282.21 on 01/09/23 |
| High | 62.90 on 03/02/21 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 325.19 on 01/31/23 |
| 3-Month | |||||
| %Chg | +297.42% since 12/28/20 | -5.14% since 11/03/22 | -7.79% since 11/03/22 | +6.34% since 11/03/22 | -3.30% since 11/03/22 |
| Low | 14.55 on 12/31/20 | 69.80 on 02/02/23 | 236.37 on 02/02/23 | 78.39 on 11/04/22 | 282.21 on 01/09/23 |
| High | 62.90 on 03/02/21 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| 6-Month | |||||
| %Chg | +390.60% since 09/28/20 | +2.00% since 08/03/22 | -0.80% since 08/03/22 | +35.70% since 08/03/22 | +9.45% since 08/03/22 |
| Low | 10.28 on 10/28/20 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 60.62 on 08/05/22 | 272.10 on 08/05/22 |
| High | 62.90 on 03/02/21 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,772,436 | 158,292,608 | 130,817,560 | 105,983,616 | 77,269,128 |
| Shares Outstanding, K | 29,516 | 2,126,160 | 533,579 | 1,254,244 | 256,691 |
| Annual Sales | 8,780,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -38,110,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 2,630,000 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,334,300,000 |
| Last Quarter Net Income | -11,900,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 930,500,000 |
| 60-Month Beta | N/A | 0.43 | 0.63 | 0.39 | 0.47 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.82 on 02/02/23 | 4.09 on 01/31/23 | 1.67 on 02/02/23 | 4.01 on 10/27/22 |
| Latest Earnings Date | 04/05/21 | 02/02/23 | 01/31/23 | 02/02/23 | 02/07/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 03/14/23 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.45 | 13.94 | 11.20 | 23.00 |
